Pet predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Fluorodeoxyglucose F18
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Tomography, Emission-Computed

abstract

  • (18)F-FDG PET after 1 cycle of chemotherapy is predictive of 18-mo outcome in patients with aggressive NHL and HD and may earlier identify patients who would benefit from more intensive treatment programs.

publication date

  • August 15, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 12163626

Additional Document Info

start page

  • 1018

end page

  • 27

volume

  • 43

number

  • 8